Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
312.58
-1.96 (-0.62%)
Streaming Delayed Price
Updated: 11:06 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
3 High-Yielding Dividend Stocks Trading Near Their 52-Week Lows
October 08, 2021
They may not be growth machines, but these stocks can generate a whole lot of dividend income for you.
Via
The Motley Fool
Debt Ceiling Agreement Helps Benchmarks Win 3 Straight
October 07, 2021
Better-than-expected jobless claims data for the week also boosted sentiment, with reopening and tech stocks leading the charge.
Via
Talk Markets
Amgen Highlights Lumakras Combination Data From Solid Tumor Trials
October 07, 2021
Amgen Inc (NASDAQ: AMGN) announced new combination study results from the Phase 1b CodeBreaK 101 study of Lumakras (sotorasib) for KRAS G12C-mutated...
Via
Benzinga
Amgen, Neumora Collaborate On Precision Therapies for Brain Diseases
October 07, 2021
Amgen Inc (NASDAQ: AMGN) and Neumora Therapeutics Inc have announced a strategic collaboration to advance neuroscience discovery, development, and...
Via
Benzinga
11 Dividend Contenders For Growth And Income
October 06, 2021
Despite the general high valuation of the overall market, these research candidates are currently sound and attractive.
Via
Talk Markets
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
Biohaven Surges To Record High As Kardashian-Backed Migraine Drug Outperforms — Again
October 05, 2021
This company sells a migraine medicine backed by Khloe Kardashian.
Via
Investor's Business Daily
Amgen's Repatha Scores FDA Nod For Pediatric Patients Over 10 Years With Inherited Heart Disease
September 27, 2021
The FDA has approved Amgen Inc's (NASDAQ: AMGN) Repatha (evolocumab) as an adjunct for pediatric patients aged 10 years and older with heterozygous familial...
Via
Benzinga
Exposures
Product Safety
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Frothy rumors about possible M&A discussions at Acceleron Pharma Inc (NASDAQ: XLRN) were capped with a Bloomberg report asserting that the Company is...
Via
Benzinga
Where to Invest $100 Right Now
September 22, 2021
These choices may surprise you.
Via
The Motley Fool
Why Verastem Stock Spiked Today
September 20, 2021
A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:
Via
Benzinga
Why Mirati Therapeutics Is A Dangerous Rival To Amgen In Colon Cancer
September 20, 2021
Mirati Therapeutics easily beat Amgen's test results in colon cancer.
Via
Investor's Business Daily
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
September 20, 2021
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).
Via
InvestorPlace
Visualizing the World’s Biggest Pharmaceutical Companies
September 17, 2021
Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.
Via
Talk Markets
Exposures
COVID-19
Apple And Microsoft Lead The Dow Jones Lower
September 17, 2021
U.S. indices were trading lower again Friday as stocks continue September weakness. As was the case Thursday, initial jobless claims came in higher than expected, which has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
40 Consistent Attractively Valued Dividend Growth Stocks
September 16, 2021
hese companies have consistent long-term operating history and solid prospects for future growth.
Via
Talk Markets
Amgen's Lumakras Combo Therapy Shows Improved Response Rate In Colorectal Cancer
September 16, 2021
Amgen Inc (NASDAQ: AMGN) announced data from a Phase 1b/2 study evaluating the combination of Lumakras (sotorasib) with Vectibix (panitumumab) in patients with KRAS G12C-...
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
These Promising Clinical Results Could Be Huge for Amgen Investors
September 11, 2021
New data from the phase 3 trial of tezepelumab bodes well for the drug candidate becoming a significant revenue producer in the near future.
Via
The Motley Fool
Dow, SPX Nab 4th-Straight Loss Despite Upbeat Jobs Data
September 09, 2021
The Dow walked away with another loss, falling triple digits and locking in its fourth-straight dip.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Amgen Reveals Post-Hoc Data For Its KRAS Inhibitor In Lung Cancer Patients
September 09, 2021
Amgen Inc (NASDAQ: AMGN) announced results from two analyses of the Phase 2 CodeBreaK 100 trial evaluating Lumakras (sotorasib). Lumakras, a KRASG12C...
Via
Benzinga
Downgrades On Economy And Pandemic Pharmaceuticals
September 08, 2021
The futures markets are pointing to a lower open on Wednesday, weighed down by European markets. The uncertainty around infrastructure, stimulus, a...
Via
Benzinga
Topics
Economy
Exposures
Economy
3 Beaten-Up Stocks for Bargain Hunters
September 08, 2021
Looking for a deal? Don't overlook these stocks.
Via
The Motley Fool
Disney And Apple Lead The Dow Jones
September 07, 2021
U.S. indices had a mixed day of trading Tuesday as investors continue to weigh an increase in COVID-19 deaths nationwide. President Biden on Thursday will lay out a six-pronged...
Via
Benzinga
Topics
Death
Stocks
Exposures
COVID-19
Death
US Equities
Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab
September 07, 2021
Amgen Inc (NASDAQ: AMGN) announced new data from the NAVIGATOR Phase 3 trial evaluating tezepelumab in patients who also have nasal polyps, a common complication...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
September 07, 2021
Upgrades BMO Capital upgraded the previous rating for BRP Inc (NASDAQ:
Via
Benzinga
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks in August?
September 02, 2021
Pullbacks have translated into lower prices, but not every lower-priced name is worth purchasing just yet.
Via
The Motley Fool
Topics
Stocks
Exposures
COVID-19
US Equities
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.